News tagged with b cell lymphoma
Study reveals how fusion protein triggers cancer
What happens when two proteins join together? In this case, they become like a power couple, where the whole is greater than the sum of the parts.
Jan 27, 2011 |
4.3 / 5 (3) |
1
|
Scientists find new way to attack cancerous cells
Scripps Research Institute scientists have discovered a new way to target and destroy a type of cancerous cell. The findings may lead to the development of new therapies to treat lymphomas, leukemias, and related cancers.
Jun 07, 2010 |
5 / 5 (11) |
0
|
Protein complex key in avoiding DNA repair mistakes, cancer
As the body creates antibodies to fight invaders, a three-protein DNA repair complex called MRN is crucial for a normal gene-shuffling process to proceed properly, University of Michigan research shows.
Aug 05, 2009 |
4.7 / 5 (3) |
0
Experimental drug lets B cells live and lymphoma cells die
(PhysOrg.com) -- An investigative drug deprived non-Hodgkin lymphoma cells of their ability to survive too long and multiply too fast, according to an early study published recently in the journal Experimental He ...
Medicine & Health / Medical research
Sep 21, 2009 |
not rated yet |
0
Gene linked to increasingly common type of blood cancer
California and Arizona researchers have identified a gene variant that carries nearly twice the risk of developing an increasingly common type of blood cancer, according to a study published online today by the science journal ...
Jul 20, 2009 |
5 / 5 (1) |
0
Bcl6 gene sculpts helper T cell to boost antibody production
Expression of a single gene programs an immune system helper T cell that fuels rapid growth and diversification of antibodies in a cellular structure implicated in autoimmune diseases and development of B cell lymphoma, scientists ...
Medicine & Health / Medical research
Jul 23, 2009 |
5 / 5 (1) |
0
Anti-inflammatory drugs may defeat a treatment-resistant type of cancer
(PhysOrg.com) -- Effective drugs for treating a chemotherapy-resistant form of lymphoma might already be on the market according to a study that has pieced together a chemical pathway involved in the disease.
Jun 24, 2009 |
5 / 5 (1) |
0
A better target for B-cell lymphomas: From a library of MAG antagonists to nanomolar CD22 ligands
Patients suffering from B-cell lymphomas can be treated with antibodies directed against the B-lymphocyte antigen CD20.
Oct 25, 2011 |
not rated yet |
0
|
A new target for lymphoma therapy
Researchers at the Program in Cellular and Molecular Medicine and the Immune Disease Institute at Children's Hospital Boston (PCMM/IDI) have found a link between a common mutation that can lead to cancer and ...
Dec 09, 2009 |
not rated yet |
0
Scientists announce advance in understanding body's natural defenses
Medical Research Council (MRC) scientists at the University of Leicester have made a new advance in understanding how the body fights certain types of cancer and other disease such as Lupus and rheumatoid arthritis.
Medicine & Health / Medical research
Mar 11, 2010 |
not rated yet |
0
Small molecule targets B cell lymphoma
Scientists are one step closer to developing a targeted therapy for lymphoma. New research, published by Cell Press in the April 13th issue of the journal Cancer Cell, identifies a specific small-molecule inhibitor that w ...
Apr 12, 2010 |
5 / 5 (2) |
0
Scientists identify possible gene target for treating a form of lymphoma
Researchers have identified a mutation in a gene that could lead to targeted therapies for certain lymphoma patients whose cure rates are currently poor. Mutation of the MYD88 gene was found to be one of the most frequent ...
Dec 22, 2010 |
not rated yet |
0
Researchers find new way to attack inflammation in Graves' eye disease
A small group of patients with severe Graves' eye disease experienced rapid improvement of their symptoms — and improved vision — following treatment with the drug rituximab. Inflammation around their eyes and damage to the ...
Medicine & Health / Diseases, Conditions, Syndromes
Nov 06, 2009 |
not rated yet |
0
Two targeted therapies likely better than one in patients with aggressive lymphoma
When combined with a cocktail of chemotherapy drugs, two monoclonal antibodies, instead of one, appear to offer superior results in patients with diffuse large B-cell lymphoma, according to Mayo Clinic researchers working ...
May 15, 2009 |
not rated yet |
0
Patent awarded for method to dampen immune response
National Jewish Health has been issued a US patent claiming a method to desensitize B cells by inactivating antigen receptors on their surfaces. The method, discovered by John Cambier, PhD, Chairman of the Integrated Department ...
Medicine & Health / Medical research
Jan 18, 2011 |
not rated yet |
1
